Web18.8.2024 – EPFL startup Rheon Medical has developed the world’s first adjustable glaucoma drainage system, which has already been used successfully in over 250 patients in Europe. The company, based at EPFL Innovation Park, closed a CHF 5.6 million Series C funding round in December 2024 and just received the U.S. FDA’s Breakthrough Device … WebAccordingly, the shunts described herein can be manipulated into a variety of configurations that provide different drainage rates based on a degree to which the ports and/or flow lumens are blocked or unblocked, therefore providing a titratable glaucoma therapy for draining aqueous from the anterior chamber of the eye.

eyeWatch Glaucoma Drainage Device - YouTube

WebCamille Furnandiz’s Post Camille Furnandiz Surgical Sales Manager at Medix21 Surgical 6d Webcal trial. Patients suffering from refractory glaucoma after failed surgeries and requiring a further glaucoma procedure including an aqueous shunt were enrolled in this study. The … gulf coast express pipeline targa

eyeWatch™ System Combined with Non-plated Intraorbital Tube …

WebDec 25, 2024 · The eyeWatch implant (eW) (Rheon Medical, Switzerland) is a novel device in glaucoma surgery aiming to control aqueous flow through an external, non-invasive … WebJul 1, 2024 · This study aims to test a new medical device, called the eyeWatch, used in filtering surgery for the treatment of glaucoma. This medical device has the following property: it allows better control of intraocular pressure in the initial postoperative phase by adjusting aqueous flow going through the device. WebMay 19, 2024 · 19.05.2024. The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Rheon Medical’s eyeWatch technology, the world’s first adjustable glaucoma shunt for the treatment of refractory glaucoma. Currently marketing the device in European and Asian markets, the company expects to initiate … gulf coast expeditions reviews